Anti-seizure meds increase suicidality…per FDA
A release by the FDA warns practitioners that anti-seizure meds increase the suicidality of patients as compared to placebo. There is no doubt that a practitioner should be including this information on Informed Consent.
“The higher risk of suicidal thoughts and behaviors was observed at one week after starting a drug and continued to at least 24 weeks. The results were generally consistent among all the different drug products studied and were seen in all demographic subgroups. There was no clear pattern of risk across age groups.”
See the letter and list of meds here: http://www.fda.gov/bbs/topics/NEWS/2008/NEW01786.html